Regeneron Pharmaceuticals, Inc.
NASDAQ:REGNBiotechnology
Healthcare
$945.53 -0.90%
-$5.45 today
- Market cap
- $97.80B
- Beta
- 0.24
- P/E (TTM)
- 14.2
- EPS (TTM)
- $42.53
- Dividend yield
- 0.60%
52W Low $506.38High $821.11
Volume 0.70M
Average 0.91M
News
For Regeneron Pharmaceuticals, Inc., read summarized stories built from several publishers and recent headlines with links to the original coverage.
Stories
All market newsNo stories for REGN yet. A story appears once at least three publishers cover the same event.
More headlines
Recent coverage that has not been summarized. Links open the publisher's site.
- Regeneron Pharmaceuticals Sees Growth Ahead, Eyes EYLEA HD Syringe Approval
MarketBeat
- Regeneron Pharmaceuticals, Inc. (REGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha
- Regeneron Pharmaceuticals, Inc. $REGN Position Lifted by Banco Santander S.A.
Defense World
- Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by AlTi Global Inc.
Defense World
- REGN Price Forecast: Rally Faces Resistance After 37% Advance
FXEmpire
Continue the stock analysis
Jump to another research area for this company.